317 related articles for article (PubMed ID: 11979328)
1. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1.
Nakane M; Hsieh G; Miller LN; Chang R; Terranova MA; Moreland RB; Kolasa T; Brioni JD
Int J Impot Res; 2002 Apr; 14(2):121-7. PubMed ID: 11979328
[TBL] [Abstract][Full Text] [Related]
2. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
3. BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro.
Kalsi JS; Rees RW; Hobbs AJ; Royle M; Kell PD; Ralph DJ; Moncada S; Cellek S
J Urol; 2003 Feb; 169(2):761-6. PubMed ID: 12544359
[TBL] [Abstract][Full Text] [Related]
4. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats.
Hsieh GC; O'Neill AB; Moreland RB; Sullivan JP; Brioni JD
Eur J Pharmacol; 2003 Jan; 458(1-2):183-9. PubMed ID: 12498924
[TBL] [Abstract][Full Text] [Related]
5. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
[TBL] [Abstract][Full Text] [Related]
6. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat.
Mizusawa H; Hedlund P; Brioni JD; Sullivan JP; Andersson KE
J Urol; 2002 May; 167(5):2276-81. PubMed ID: 11956492
[TBL] [Abstract][Full Text] [Related]
8. Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction.
Brioni JD; Nakane M; Hsieh GC; Moreland RB; Kolasa T; Sullivan JP
Int J Impot Res; 2002 Feb; 14(1):8-14. PubMed ID: 11896472
[TBL] [Abstract][Full Text] [Related]
9. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
Wegener JW; Gath I; Förstermann U; Nawrath H
Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
11. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
12. Nerve-induced release of nitric oxide from the rabbit corpus cavernosum is modulated by cyclic guanosine 3',5'-monophosphate.
Hallén K; Gustafsson LE; Wiklund NP
Neuroscience; 2005; 133(1):169-74. PubMed ID: 15893640
[TBL] [Abstract][Full Text] [Related]
13. Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
Dismuke WM; Sharif NA; Ellis DZ
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3353-9. PubMed ID: 19234350
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
El-Awady MS; Smirnov SV; Watson ML
Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
[TBL] [Abstract][Full Text] [Related]
16. Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats.
Rothermund L; Friebe A; Paul M; Koesling D; Kreutz R
Br J Pharmacol; 2000 May; 130(2):205-8. PubMed ID: 10807655
[TBL] [Abstract][Full Text] [Related]
17. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
Nakane M; Kolasa T; Chang R; Miller LN; Moreland RB; Brioni JD
J Pharmacol Sci; 2006 Oct; 102(2):231-8. PubMed ID: 17050951
[TBL] [Abstract][Full Text] [Related]
18. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
19. The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum.
Göçmen C; Büyüknacar HS; Kots AY; Murad F; Kiroglu O; Kumcu EK
J Pharmacol Exp Ther; 2006 Feb; 316(2):753-61. PubMed ID: 16254132
[TBL] [Abstract][Full Text] [Related]
20. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
